One study proved that this is in accordance with the REMBRANDT glioma database (834 patients) which states that a poorer patient outcome and a higher glioma grade were correlated with a higher expression of HIF-2α in tumor tissue [8]. Here, EPAS1 is linked to central nervous system cancer.